UK regulator approves second Alzheimer's drug in months but government won't pay for it
Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to taxpayers
Read more at ABC News
Topics
-
UK regulator approves second Alzheimer's drug in months but government won't pay for it
World - ABC News - October 23 -
European committee takes a second look at Alzheimer's drug and now says it should be approved
Health - ABC News - 6 days ago -
Chancellor and BoE governor call for UK to rebuild ties with EU
Business - Financial Times - 6 days ago -
Britain’s bold plan to create super funds
Business - Financial Times - 6 days ago -
Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
Business - MarketWatch - 6 days ago -
Top UK government lawyer pushes ‘revolving door’ as pay gap widens
World - Financial Times - 3 days ago -
NHS will not fund new drug to slow Alzheimer’s
Top stories - BBC News - October 23 -
German regulators approve construction of nationwide hydrogen network
World - Yahoo News - October 22 -
Nurse’s death linked to approved weight-loss drug
Top stories - BBC News - November 8
More from ABC News
-
Faulty fentanyl tests spurred NYC’s push to ban mail on Rikers Island
Health - ABC News - 12 hours ago -
Former doctor is sentenced to life in prison after conviction for sexually abusing patients
Health - ABC News - 10 hours ago -
Health advocates in Africa worry Trump will reimpose abortion 'gag rule' governing US aid
Health - ABC News - Yesterday -
What to know about Transgender Day of Remembrance and violence against trans people
Health - ABC News - 1 hour ago -
UN authorizes first mpox vaccine for children in an attempt to control Congo outbreak
Health - ABC News - 20 hours ago